The first batch of "Wo Anxin" was approved and issued, the first in China and the second in the world!

3Month31On the day, Yunnan Watson Biology released "About13The announcement of the first batch of products of the pneumococcal polysaccharide conjugate vaccine, produced by its subsidiary Yuxi Watson.13Valence pneumococcal polysaccharide conjugate vaccine(Trade name: Vo Anxin) First batch of products141,119Branch, has been issued by the State Drug Administration.Certificate of Batch Issuance of Biological Products.“Woanheim”becomeOur firstThe second global.Approved for listing13Valence pneumococcal polysaccharide conjugate vaccine.

“Woanheim”Products independently developed and produced for Watson, mainly suitable6Weeks5Years (6Before the first birthday), infants and children can be vaccinated to prevent13serotype (1Type,3Type,4Type,5Type,6AType,6BType,7FType,9VType,14Type,18CType,19AType,19FType and23FType) pneumoniacoccicausedinfectious diseases.

Streptococcus pneumoniae is the most common cause of invasive disease, pneumonia and upper respiratory tract infection, and it is also the first pathogen causing pneumonia in infants and young children. Streptococcus pneumoniae infectious diseases are leading to global5The number one cause of vaccine-preventable death among children under the age3million.5Children under the age of 1 died of infectious disease caused by Streptococcus pneumoniae.ForPneumonia is a disease infection.Prevention is better than cure. The World Health Organization (WHO) has beenPneumonia is a disease infection.Listed as required“Very high priority”Diseases prevented by the use of vaccines.

13Valence pneumococcal polysaccharide conjugate vaccineThe polysaccharide is covalently bound to the protein carrier by chemical methods, and this protein carrier can induce immunity, which is conducive to promoting long-term immune memory, and more importantly, it can make2Babies under the age of effectively produce antibodies.It can be said that this vaccine is very important, but it is extremely difficult to develop..

Previously, globally available for infants and young children13The price pneumococcal polysaccharide conjugate vaccine is only produced by Pfizer. Pfizer's Pneumonia VaccinePei Er.13®In2012year inFDAApproved,2016Approved for listing in China.Pei Er.13®At present, it has been included in the immunization planning of many countries and regions in the world and Asia Pacific2019Global sales in58.5Billions of dollars, sit tight“The World's Best Selling Vaccines”The throne.

In mainland China, from2016approved for entry in,Pei Er.13®The number of batches issued is increasing year by year,2020year475.50Ten thousand, but compared with the huge and growing market demand, it is a drop in the bucket, and the supply is often in short supply. The vaccine is repeatedly out of stock in the domestic market, making many parents who are interested in vaccination helpless. Global market13Valence pneumococcal polysaccharide conjugate vaccineThe demand is also large, and there is a large gap in supply.

“Woanheim”ForOur firstThe second global.Approved for listing13Valence pneumococcal polysaccharide conjugate vaccine, which was approved for marketing.WillBreaking the monopoly of foreign pharmaceutical company Pfizer in the field of infant pneumococcal conjugate vaccine,form a strong competition for it. Watson Creature13The person in charge of the pneumococcal polysaccharide conjugate vaccine project revealed that after the first batch of products is issued, the amount of batches issued in the later period will gradually increase. Watson Biology is in2020The first half of the year can supply to the market near100Ten thousand“Woanheim”In the future, the annual production capacity can reach300010,000 units, can effectively alleviate some of the market demand.

In terms of patents, Yunnan Watson Biotechnology Co., Ltd.In2018Year5Month29Day SubmissionThe title is“a kind13Valuable pneumoniaPolysycharide shards-Protein conjugate composition and preparation method and application thereof”Application for Invention,and in2018Year5Month29Published on the day, the patent is.CN108079286AIt is currently in the substantive review stage.

Of course, Watson Creatures are not the only ones in the country to target.13Price pneumonia vaccine market. At present, in addition to Watson Bio, there are pharmaceutical companies or companies such as Minhai Bio, Beijing Kexing, Lanzhou Institute, Zhifei Bio, Kangsinuo and Chengdu Antejin.13The price of the pneumonia vaccine is developed.We look forward to more domestic pharmaceutical companies in the future.The field of pneumococcal conjugate vaccines shines.